Danish Drugmaker Ready to Cash In with 10 Million Monkeypox Vaccine Doses Set for Production Following WHO’s Global Health Emergency Declaration
Credit: Getty Images
Danish drugmaker Bavarian Nordic is poised to begin large-scale production of its monkeypox vaccine.
The company’s rapid response comes in the wake of the World Health Organization’s (WHO) recent declaration of a global health emergency concerning the monkeypox outbreak.
The WHO’s emergency committee convened amid alarming reports of a more virulent strain of monkeypox spreading across four additional regions in Africa.
As of mid-August 2024, over 17,000 cases and more than 500 deaths have been reported across 13 African nations, with the outbreak initially contained to the Democratic Republic of Congo.
WHO Director-General Tedros Adhanom Ghebreyesus emphasized the “severity” of the situation during a virtual meeting with independent experts.
Following their recommendations,
